Venus Remedies Limited — Imipenem Exporter Profile
Indian Pharmaceutical Exporter · #1 for Imipenem · $9.9M export value · DGFT Verified
Venus Remedies Limited is the #1 Indian exporter of Imipenem with $9.9M in export value and 194 verified shipments. Venus Remedies Limited holds a 29.1% market share in Imipenem exports across 27 countries. The company exports 29 pharmaceutical products worth $86.4M across 6 therapeutic categories.
Venus Remedies Limited — Imipenem Export Profile: Buyers & Destinations
Where Does Venus Remedies Limited Export Imipenem?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MEXICO | $1.1M | 22 | 32.2% |
| SAUDI ARABIA | $754.7K | 78 | 22.1% |
| CHILE | $350.1K | 8 | 10.2% |
| SOUTH AFRICA | $290.2K | 8 | 8.5% |
| BELGIUM | $157.5K | 10 | 4.6% |
| VENEZUELA | $129.2K | 7 | 3.8% |
| PERU | $100.0K | 2 | 2.9% |
| JAMAICA | $71.8K | 7 | 2.1% |
| UGANDA | $71.0K | 12 | 2.1% |
| GERMANY | $67.4K | 9 | 2.0% |
Venus Remedies Limited exports Imipenem to 28 countries. The largest destination is MEXICO accounting for 32.2% of Venus Remedies Limited's Imipenem shipments, followed by SAUDI ARABIA (22.1%) and CHILE (10.2%). These destinations reflect Venus Remedies Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Imipenem from Venus Remedies Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| S T C | SAUDI ARABIA | $459.6K | 37 |
| LABORATORIOS JAYOR S.A. DE C.V. | MEXICO | $400.0K | 8 |
| LABORATORIOS JAYOR S A DE C V | MEXICO | $200.0K | 4 |
| L J S.A DE CV | MEXICO | $200.0K | 4 |
| SALEHIYA TRADING COMPANY | SAUDI ARABIA | $171.6K | 24 |
| ASCEND LABORATORIES SPA AVENIDA APOQUINDO | CHILE | $150.0K | 3 |
| A L SPA, | CHILE | $150.0K | 3 |
| P D | SOUTH AFRICA | $150.0K | 3 |
| LABORATORIOS JAYOR, S. A. DE C. V | MEXICO | $100.0K | 2 |
| L J S A D C | MEXICO | $100.0K | 2 |
Venus Remedies Limited supplies Imipenem to 68 buyers globally. The largest buyer is S T C (SAUDI ARABIA), followed by LABORATORIOS JAYOR S.A. DE C.V. (MEXICO) and LABORATORIOS JAYOR S A DE C V (MEXICO). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Imipenem Export Value and How Much Does Venus Remedies Limited Contribute?
India exported $20.1M worth of Imipenem through 803 shipments from 140 suppliers to 94 countries, serving 302 buyers globally. Venus Remedies Limited contributes $9.9M to this total, accounting for 29.1% of India's Imipenem exports. Venus Remedies Limited ships Imipenem to 28 countries through 68 buyers.
What Is the Average Shipment Value for Venus Remedies Limited's Imipenem Exports?
Venus Remedies Limited's average Imipenem shipment value is $50.9K per consignment, based on 194 shipments totaling $9.9M. The largest destination is MEXICO (32.2% of Venus Remedies Limited's Imipenem exports).
How Does Venus Remedies Limited Compare to Other Indian Imipenem Exporters?
Venus Remedies Limited ranks #1 among 140 Indian Imipenem exporters with a 29.1% market share. The top 3 exporters are VENUS REMEDIES LIMITED ($9.7M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($6.0M), PROTECH BIO SYSTEMS PRIVATE LIMITED ($950.0K). Venus Remedies Limited processed 194 shipments to 27 destination countries.
What Imipenem Formulations Does Venus Remedies Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| SENSIMITINA 500MG (IMIPENEM / CILASTATIN | $200.0K | 4 |
| IMPRACID 500MG- (IMIPENEM/CILASTATIN POWDER FOR INJECTABLE SOLUTION 500MG/500MG)NOS | $150.0K | 3 |
| LASTINEM 500 MG (IMIPENEM AND CILASTATIN500MG +500MG POWDER FOR SOLUTION FOR INFUSTION)NOS | $150.0K | 3 |
| IMIPENEM AND CILASTATIN FOR INJECTION U. | $118.3K | 3 |
| SENSIMITINA 500MG (IMIPENEM/CILASTATIN 5 | $100.0K | 2 |
| SENSIMITINA IMIPENEM / CILASTATIN 500 MG / 500 MG SOLUTION FOR INJECTION SENSIMITINA 500MG | $100.0K | 2 |
| SENSIMITINA500MGIMIPENEM/CILASTATIN500MG/500MG SOLUTION FOR INJECTIONE.VIAL W/POWDER CNT:IMIPENEM MONOHYDRATE EQ.500MG | $100.0K | 2 |
| IMIPENEM AND CILASTATIN 500MG (IMIPENEM/CILASTATIN 500MG/500MG SOLUTION FOR INJECTION) | $100.0K | 2 |
| IMIPENEM AND CILASTATIN FOR INJECTION U.S.P (500MG/10ML) (SENSIMITINA 500MG) | $100.0K | 2 |
| LASTINEM 500 MG (IMIPENEM AND CILASTATIN | $94.5K | 5 |
Venus Remedies Limited exports 150 distinct Imipenem formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SENSIMITINA 500MG (IMIPENEM / CILASTATIN with 4 shipments worth $200.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Imipenem to Key Markets
What Venus Remedies Limited must comply with to export Imipenem to its top destination countries
Mexico — COFEPRIS
Approval Process
Generic registration under Mexican health law. NOM standards apply.
Timeline: 12–18 months
GMP & Export Requirements
Mexican GMP (NOM-059-SSA1); COFEPRIS overseas inspection or PIC/S certificate
Sanitary Import Permit from COFEPRIS; import licence via SAT
Note: COFEPRIS participates in PIC/S, easing recognition of PIC/S certificates from Indian authorities.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Venus Remedies Limited Compare to Nearest Imipenem Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | VENUS REMEDIES LIMITED ★ | $9.7M | 194 | 27 | $50.0K |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $6.0M | 119 | 17 | $50.0K |
| 5 | PROTECH BIO SYSTEMS PRIVATE LIMITED | $950.0K | 19 | 2 | $50.0K |
Venus Remedies Limited ranks #1 among 140 Indian Imipenem exporters. Average shipment value of $50.0K compared to the market average of $143.4K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and PROTECH BIO SYSTEMS PRIVATE LIMITED.
Which Indian Ports Ship Imipenem Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 114 | 14.2% |
| DELHI AIR | 83 | 10.3% |
| SAHAR AIR | 76 | 9.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 57 | 7.1% |
| NHAVA SHEVA SEA (INNSA1) | 37 | 4.6% |
| Delhi Air | 34 | 4.2% |
| DHANNAD ICD | 30 | 3.7% |
| DHANNAD ICD (INDHA6) | 27 | 3.4% |
What Other Advanced Antibiotics Products Does Venus Remedies Limited Export?
Venus Remedies Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Venus Remedies Limited's Imipenem Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Venus Remedies. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing transit times and costs for exports to Europe and the Americas. Such disruptions necessitate strategic adjustments in logistics and supply chain management to maintain timely deliveries and cost-effectiveness.
Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their presence in the U.S. market. India now supplies 40% of the U.S.'s generic drug needs, reflecting a growing reliance on Indian manufacturers. (ibef.org) Venus Remedies' recent QIDP designation from the U.S. FDA for VRP-034 positions the company favorably to leverage this opportunity, potentially enhancing its market share in the U.S.
In the European Union, compliance with the Falsified Medicines Directive (FMD) remains critical. Venus Remedies' renewal of the EU-GMP certification indicates their proactive approach to meeting stringent EU regulations, thereby ensuring continued access to European markets. (business-standard.com)
Venus Remedies Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for pharmaceutical exporters. Venus Remedies has demonstrated a consistent commitment to quality, as evidenced by multiple GMP certifications. In addition to the EU-GMP renewal, the company secured GMP certification from Moldova's Ministry of Health in January 2025, covering their antibiotic-carbapenem manufacturing facility. (apnnews.com) Furthermore, the renewal of Ukrainian GMP certification in May 2025 for their Baddi facility underscores their adherence to global quality standards. (apnnews.com)
These certifications not only facilitate market access but also enhance the company's reputation as a reliable supplier of high-quality pharmaceuticals. In an industry where regulatory compliance is closely scrutinized, Venus Remedies' proactive measures position them favorably among global competitors.
About Venus Remedies Limited
Venus Remedies Limited exports 29 products worth $86.4M. Beyond Imipenem, top products include Meropenem, Enoxaparin, Ceftriaxone, Paclitaxel, Carboplatin. View the complete Venus Remedies Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Imipenem — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Imipenem shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Venus Remedies Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 201 individual customs records matching Venus Remedies Limited exporting Imipenem, covering 150 formulations to 28 countries via 68 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 94+ countries, 302+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Imipenem Export Data from Venus Remedies Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Venus Remedies Limited's Imipenem exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Venus Remedies Limited
Full Company Profile →
29 products · $86.4M total trade · 6 categories
Imipenem Stats
Company Overview
Top Products by Venus Remedies Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Venus Remedies Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Imipenem. For current shipment-level data, contact TransData Nexus.